What is Fredun Pharmaceuticals Ltd (539730) share price return in the past 10 years?

Fredun Pharmaceuticals Ltd share price has appreciated 65.2% annually (CAGR) over the past ten years.

What is the share price of Fredun Pharmaceuticals Ltd (539730)?

Company share prices are keep on changing according to the market conditions. The current trading price of Fredun Pharmaceuticals Ltd (539730) on 04-Jun-2026 16:59:59 at 16:59 is 2301.95.

What is the P/E ratio of Fredun Pharmaceuticals?

The latest standalone P/E ratio of Fredun Pharmaceuticals as of 04-Jun-2026 is 38.21.

What is the P/B ratio of Fredun Pharmaceuticals Ltd (539730)?

The latest standalone P/B ratio of Fredun Pharmaceuticals Ltd (539730) as of 04-Jun-2026 is 4.47.

What is the 52-week high and low of Fredun Pharmaceuticals Ltd (539730)?

The 52-week high of Fredun Pharmaceuticals Ltd (539730) is Rs. 2620.00 and the 52-week low is Rs. 707.90.

Fredun Pharmaceuticals Ltd (539730) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Fredun Pharmaceuticals Ltd (539730)
Brand: Fredun Pharmaceuticals

Fredun Pharmaceuticals Ltd (539730)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 539730 NSE: Pharmaceuticals & Drugs | Small Cap | Fredun Pharma Share Price

Fredun Pharmaceuticals Ltd (539730)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 539730 NSE: Pharmaceuticals & Drugs | Small Cap | Fredun Pharma Share Price

Key Metrics

Valuation Multiples

Market Cap

₹1,269 Cr.

Current Price

₹2,302

52-Week Low / High

₹708 / 2,620

TTM EPS

₹60.2

TTM Sales

₹633 Cr.

Book Value per Share

₹514.7

P/E Ratio

38.21

Higher than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

4.47

Higher than its 5-year historical median

Price to Sales (P/S)

2.00

Higher than its 5-year historical median

EV/EBITDA

15.04

In line with its 5-year historical median

Dividend Yield

0.10%

Profitability Efficiency

Return on Equity (ROE)

15.93%

Outperforms industry median

Return on Capital Employed (ROCE)

18.94%

Outperforms industry median

Return on Assets (ROA)

5.24%

Operating Profit Margin

11.8%

Net Profit Margin

4.59%

Gross Profit Margin

7.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

30.35%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

38.63%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

33.23%

Asset Quality

Promoter Holding

44.17%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹278 Cr.

Equity

₹5.5 Cr.

Face Value

₹10

All Time Low / High

₹12.50 / 2620.00

Fredun Pharmaceuticals stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Fredun Pharmaceuticals Ltd a good quality company?

Fredun Pharmaceuticals Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Fredun Pharmaceuticals Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Fredun Pharmaceuticals Ltd vs industry peers?

Fredun Pharmaceuticals Ltd revenue CAGR is 32.11%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Fredun Pharmaceuticals Ltd?

Promoters hold 44.17% of the Fredun Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Fredun Pharmaceuticals Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 67.3% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	24.7%	18.2%	15.9%	20.6%	10.4%	9.5%	13.2%	17.6%	17.1%	18.9%	-
Value Creation Index ⓘ	0.8	0.3	0.1	0.5	-0.3	-0.3	-0.1	0.3	0.2	0.4	-
Growth Parameters ⓘ
Sales ⓘ	42.3	56.7	59.6	97	113	134	224	275	348	454	633
Sales YoY Gr.	-	34%	5%	62.9%	16.2%	18.7%	67.7%	22.4%	26.8%	30.4%	-
Adj EPS ⓘ	4.4	3.5	4.9	11.5	4.4	4.9	12.4	21.6	32.2	44	60.2
YoY Gr.	-	-20.7%	38.4%	136.6%	-62.2%	13.3%	151.6%	73.5%	49.3%	36.7%	-
BVPS (₹) ⓘ	15.7	20.1	64.7	97.7	103.6	108	153.1	194.3	255.2	299.5	514.7
Adj Net Profit ⓘ	1.1	0.8	1.7	4.6	1.7	2	5.5	9.8	15.1	20.8	33
Cash Flow from Ops. ⓘ	3.3	4	17.3	0.8	-10.6	0.2	-2.4	-14.4	-0.4	-28.9	-
Debt/CF from Ops. ⓘ	4.7	4.6	0.6	23.1	-3.3	233.3	-22.2	-6	-240.5	-5.8	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	30.2%	32.1%	26.5%	30.4%
Adj EPS ⓘ	29%	58.8%	52.4%	36.7%
BVPSⓘ	38.8%	23.7%	25.1%	17.4%
Share Price	65.2%	40.2%	40%	215.1%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	29.7	14.8	11.3	15	4.3	4.7	9.9	11.9	13.9	15.8	14.8
Op. Profit Mgn % ⓘ	9.8	6	9.6	10.5	7.4	7	6.2	10.1	10.9	11.8	15
Net Profit Mgn % ⓘ	2.5	1.5	2.8	4.7	1.5	1.5	2.5	3.6	4.3	4.6	5.2
Debt to Equity ⓘ	3.9	2.5	0.5	0.5	0.8	0.9	0.8	1	0.9	1.2	0.2
Working Cap Days ⓘ	174	200	261	230	290	324	230	244	248	276	114
Cash Conv. Cycle ⓘ	28	12	-31	15	98	111	100	135	149	166	40

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	42	57	60	97	113	134	224	275	348	454
Operating Expenses ⓘ +	38	53	54	87	104	125	211	247	310	401
Manufacturing Costs	11	17	3	7	7	6	8	11	15	21
Material Costs	19	25	40	60	82	102	177	209	261	330
Employee Cost	4	5	5	8	9	9	11	12	12	22
Other Costs ⓘ	5	7	6	12	7	8	15	16	22	28
Operating Profit ⓘ	4	3	6	10	8	9	14	28	38	53
Operating Profit Margin (%)	9.2%	5.9%	9.6%	10.3%	7.4%	7.0%	6.2%	10.1%	10.9%	11.6%
Other Income ⓘ +	1	2	0	1	1	1	2	2	1	2
Exceptional Items ⓘ	-0	0	0	0	0	-1	0	0	0	0
Interest ⓘ	2	2	2	3	4	4	5	9	14	22
Depreciation ⓘ	1	1	1	1	2	2	2	3	4	4
Profit Before Tax ⓘ	2	2	3	6	2	3	9	18	21	28
Tax ⓘ	1	1	1	2	1	1	2	7	6	7
Profit After Tax	1	1	2	4	2	2	6	11	16	21
PAT Margin (%)	2.5%	2.5%	2.9%	4.6%	1.7%	1.5%	2.8%	3.9%	4.5%	4.6%
Adjusted EPS (₹)	4.5	5.4	4.2	11.2	4.8	5.1	14.3	23.8	33.3	44.1
Dividend Payout Ratio (%)	13.50%	11.20%	14.40%	5.80%	13.80%	13.90%	4.90%	2.90%	2.10%	1.60%

Valuation of Fredun Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	4	7	22	39	41	43	68	88	120	141
Share Capital ⓘ	3	5	3	4	4	4	4	5	5	5
Reserves ⓘ	1	2	19	35	37	39	63	84	115	137
Debt +	13	15	10	19	35	40	53	83	100	159
Long Term Debt	6	7	0	11	11	29	42	15	13	10
Short Term Debt	7	8	10	9	23	11	11	68	87	150
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	16	23	39	34	46	60	49	59	63	145
Others Liabilities ⓘ	10	11	8	13	19	19	18	27	25	41
Total Liabilities ⓘ	43	56	79	105	141	162	187	257	308	487
Fixed Assets
Net Fixed Assets ⓘ +	15	21	16	31	31	30	32	39	47	53
Gross Block	21	28	25	35	37	38	42	52	69	80
Accumulated Depreciation	6	7	9	4	6	8	10	13	23	27
CWIP ⓘ	0	0	11	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	1	2
Inventories	10	7	18	41	50	68	46	150	175	240
Trade Receivables	11	20	15	18	39	41	90	35	65	177
Cash Equivalents	1	1	1	1	3	1	2	3	1	5
Others Assets ⓘ	6	8	17	14	18	21	16	30	19	11
Total Assets ⓘ	43	56	79	105	141	162	187	257	308	487

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	3	4	17	1	-11	0	-2	-14	-0	-29
PBT ⓘ	2	2	2	6	2	2	9	17	21	28
Adjustment ⓘ	2	2	3	2	6	9	8	12	17	27
Changes in Working Capital ⓘ	-0	-0	13	-7	-19	-10	-19	-44	-39	-84
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-6	-7	-8	-5	-1	-1	-4	-9	-8	-6
Capex	-7	-3	-1	-16	-1	-1	-4	-9	-8	-6
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	1	-4	-7	11	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	3	3	-8	4	14	-1	7	25	6	38
Net Proceeds from Shares ⓘ	5	2	-1	1	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	-4	7	1	18	13	7	-3	-3
Interest Paid ⓘ	-2	-2	-2	-3	-4	-4	-5	-9	-14	-22
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	2	-1	-0	17	-14	-1	28	22	64
Net Cash Flow ⓘ	1	-1	1	0	2	-2	1	1	-2	3

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	33.46	33.88	13.02	14.59	4.74	4.77	11.42	13.86	15.03	15.93
ROCE (%)	24.67	18.16	15.9	20.56	10.36	9.53	13.15	17.64	17.13	18.94
Asset Turnover Ratio	1.28	1.14	0.88	1.05	0.92	0.88	1.29	1.24	1.23	1.14
PAT to CFO Conversion(x)	3	4	8.5	0.25	-5.5	0	-0.33	-1.27	-0	-1.38
Working Capital Days
Receivable Days	71.50	102.30	109.20	62.20	91.90	109.10	106.80	82.90	52.10	97.30
Inventory Days	62.80	55.40	77.70	111.40	147.70	160.90	92.70	130.60	170.40	166.80
Payable Days	223.10	290.40	285.20	221.40	178.40	189.50	111.90	94.40	85.40	114.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Fredun Pharmaceuticals Ltd FAQs

The current trading price of Fredun Pharma on 04-Jun-2026 16:59 is ₹2,302.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Fredun Pharma stood at ₹1,269 Cr

The latest P/E ratio of Fredun Pharma as of 03-Jun-2026 is 38.21.

The latest P/B ratio of Fredun Pharma as of 03-Jun-2026 is 4.47.

The 52-week high of Fredun Pharma is ₹2,620 and the 52-week low is ₹707.9.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fredun Pharma is ₹633 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Fredun Pharmaceuticals Ltd is a average quality company.

The key valuation ratios of Fredun Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Fredun Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Fredun Pharmaceuticals Ltd

No data to display

Fredun Pharmaceuticals Ltd (539730)

Fredun Pharmaceuticals Ltd (539730)

Fredun Pharmaceuticals stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Fredun Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Fredun Pharmaceuticals Ltd FAQs

About Fredun Pharmaceuticals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Fredun Pharmaceuticals Ltd (539730)

Fredun Pharmaceuticals Ltd (539730)

Fredun Pharmaceuticals stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Fredun Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Fredun Pharmaceuticals Ltd FAQs

What is the share price of Fredun Pharma?

What is the market cap of Fredun Pharma?

What is the P/E ratio of Fredun Pharma?

What is the P/B ratio of Fredun Pharma?

What is the 52-week high and low of Fredun Pharma?

What is the TTM revenue of Fredun Pharma?

Is Fredun Pharmaceuticals Ltd a good quality company?

Is Fredun Pharmaceuticals Ltd undervalued or overvalued?

Is Fredun Pharmaceuticals Ltd a good buy now?

About Fredun Pharmaceuticals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.